Report Overview

The APAC Dermatology Drugs Market size stood at around USD $0.3 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

Dermatology is a medical field that deals with the diagnosis, prevention, and treatment of various skin, nail, and hair-related diseases such as pigmentation, acne, wrinkles, and psoriasis. Dermatological agents, also referred to as dermatologic, are products that are applied topically to the skin. Such drugs are used for the diagnosis of skin diseases and are often used to avoid certain skin disorders. In fact, dermatological are used to protect one's skin for daily skin care. Dermatology drugs are classified into corticosteroids, antifungal drugs, immunosuppressive drugs, monoclonal antibodies, retinoids, antibiotics agent, antiviral agents, and antihistamines agents among others. Dermatology drugs can be administered orally, topically and parenteral. Dermatology drugs can cause various side-effects including neuropsychiatric disorders, facial nerve palsy, headache, dizziness, lethargy, weakness, transient sensory, motor peripheral neuropathies, demyelinating, and autoimmune disorders among others



Market Drivers

Dermatology drug demand has increased as compared to the precise year with growing awareness for diagnostics and treatment of skin diseases. In addition demand of dermatology drug has increased in the developing countries with the increased spending on healthcare. Further product recall of products having these drugs is expected to restraint the usage of dermatology drugs and is expected to slow down the growth of the dermatology drugs market in the forecasted period